LLS supports robust federal funding dedicated to cancer research. We also aim to enact policies that enhance clinical trials, promote drug development and focus on what matters most to patients.
“One of the biggest misconceptions with pediatric cancer is that once the treatments are finished, the battle is over. The consequences of the toxic therapies injected into little bodies can cause serious and sometimes life-threatening complications years later.”
- Michelle Marks, mom of pediatric cancer patient